Toward effective targeted therapies for Acute Myeloid Leukaemia (AML)
Toward effective targeted therapies for Acute Myeloid Leukaemia (AML)
批准号:
nhmrc : 1126843
负责人:
A/Pr Andrew Wei
金额:
$37.58万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2019-12-31
中文摘要
急性髓性白血病(AML)的标准化疗是高毒性的,40多年来没有改变。我们将进行世界上第一项临床试验,将ABT-199(Venetoclax)靶向BCL 2纳入AML的标准治疗。第二项计划将探索小分子抑制剂同时靶向BCL 2及其相关伴侣MCL 1的潜力,以创建AML的“无化疗”方案。这些研究预示着AML治疗的新时代。
英文摘要
Standard chemotherapy for acute myeloid leukaemia (AML) is highly toxic, and has not changed in over 40 years. We will conduct a world-first clinical trial incorporating ABT-199 (Venetoclax) to target BCL2 into the standard-of-care treatment for AML. A second initiative will explore the potential for small molecule inhibitors to simultaneously target both BCL2 and its related partner MCL1, to create a “chemotherapy-free” regimen for AML. These studies promise to herald a new era in AML therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Examining the contribution of mutant DNMT3a in the development and sustained growth of Acute Myeloid Leukaemia
-
批准号:nhmrc : GNT1145728
-
项目类别:Project Grants
-
资助金额:$82.09万
-
财政年份:2018
-
负责人:A/Pr Andrew Wei
-
依托单位:
Examining the contribution of mutant DNMT3a in the development and sustained growth of Acute Myeloid Leukaemia
-
批准号:nhmrc : 1145728
-
项目类别:Project Grants
-
资助金额:$55.5万
-
财政年份:2018
-
负责人:A/Pr Andrew Wei
-
依托单位:
Translational Research Program to Advance Clinical Outcomes in Acute Myeloid Leukaemia
-
批准号:nhmrc : 1141460
-
项目类别:Practitioner Fellowships
-
资助金额:$27.89万
-
财政年份:2018
-
负责人:A/Pr Andrew Wei
-
依托单位:
Toward effective targeted therapies for Acute Myeloid Leukaemia (AML)
-
批准号:nhmrc : GNT1126843
-
项目类别:Project Grants
-
资助金额:$55.13万
-
财政年份:2017
-
负责人:A/Pr Andrew Wei
-
依托单位:
Eradicating leukaemic stem cells by targeting the arginine methyltransferase PRMT5
-
批准号:nhmrc : 1086662
-
项目类别:Project Grants
-
资助金额:$51.41万
-
财政年份:2015
-
负责人:A/Pr Andrew Wei
-
依托单位:
Targeting IAPs in Leukaemias using the Smac-mimetic drug Birinapant
-
批准号:nhmrc : 1081376
-
项目类别:Project Grants
-
资助金额:$64.63万
-
财政年份:2015
-
负责人:A/Pr Andrew Wei
-
依托单位:
Eradicating leukaemic stem cells by targeting the arginine methyltransferase PRMT5
-
批准号:nhmrc : GNT1086662
-
项目类别:Project Grants
-
资助金额:$74.24万
-
财政年份:2015
-
负责人:A/Pr Andrew Wei
-
依托单位:
Targeting IAPs in Leukaemias using the Smac-mimetic drug Birinapant
-
批准号:nhmrc : GNT1081376
-
项目类别:Project Grants
-
资助金额:$93.25万
-
财政年份:2015
-
负责人:A/Pr Andrew Wei
-
依托单位:
Targeting the apoptosis machinery in cancer
-
批准号:nhmrc : GNT1066711
-
项目类别:Project Grants
-
资助金额:$52.79万
-
财政年份:2014
-
负责人:A/Pr Andrew Wei
-
依托单位:
Targeting the apoptosis machinery in cancer
-
批准号:nhmrc : 1066711
-
项目类别:Project Grants
-
资助金额:$36.41万
-
财政年份:2014
-
负责人:A/Pr Andrew Wei
-
依托单位:
A randomised study to optimise clinical outcomes in patients with FLT3 mutant AML
-
批准号:nhmrc : 1048312
-
项目类别:Project Grants
-
资助金额:$77.99万
-
财政年份:2013
-
负责人:A/Pr Andrew Wei
-
依托单位:
GADD45A promoter methylation and poor prognosis in AML:mechanism and clinical significance
-
批准号:nhmrc : 1024342
-
项目类别:Project Grants
-
资助金额:$47.09万
-
财政年份:2012
-
负责人:A/Pr Andrew Wei
-
依托单位:
Dual inhibition of independent cell survival pathways as a new approach for targeting leukemic stem cells
-
批准号:nhmrc : 1032248
-
项目类别:Project Grants
-
资助金额:$37.52万
-
财政年份:2012
-
负责人:A/Pr Andrew Wei
-
依托单位:
国内基金
海外基金
多跳无线 MESH 网络中 QoS 保障算法的研究设计和性能分析
-
批准号:60902041
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:杨旸
-
依托单位: